文献速递腹部技术与安全USCTMR

超声监测慢性乙型肝炎肝细胞癌的有效性:US LI-RADS可视化评分

Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
PubMed 文献 · Radiology · 2023-01-01

本研究回顾性纳入2002例接受规律超声监测的慢性乙型肝炎患者,按US LI-RADS可视化评分分为最佳组(A,972例)和次佳组(B或C,1030例)。次佳组肝癌年发生率2.38%高于最佳组0.48%(HR 4.93,95%CI 3.28-7.41,P<.001),超声假阴性率43.9%高于最佳组16.7%(OR 3.90,95%CI 1.02-15.00,P=.04)。

要点

  • US LI-RADS可视化评分B或C的慢性乙肝患者肝癌发生风险是A级的4.93倍。
  • 次佳可视化组超声假阴性率43.9%,显著高于最佳组16.7%(OR 3.90)。
  • 次佳可视化原因包括晚期肝硬化实质不均、脂肪肝穿透受限及重叠器官遮挡。

核心结论

  • 慢性乙型肝炎患者中,US LI-RADS可视化评分B或C者肝癌发生风险及超声假阴性率均高于A者。

研究设计与样本

  • 回顾性研究,连续纳入单中心三级转诊医院2002例规律超声监测肝癌的慢性乙型肝炎患者,中位年龄54岁(IQR 46-60岁),男1192例,最佳组972例、次佳组1030例,中位随访75个月(IQR 69-77个月)。

关键影像表现/征象

  • 次佳可视化原因:晚期肝硬化实质不均489例,脂肪肝穿透受限200例,重叠器官遮挡致窗口受限341例。
  • 随访期间163例发生肝癌,次佳组年发生率2.38%,最佳组0.48%。
  • 次佳组超声假阴性率43.9%,最佳组16.7%。

诊断标准与关键数值

  • US LI-RADS可视化评分A为最佳可视化,B或C为次佳可视化。
  • 次佳组较最佳组肝癌风险HR 4.93(95%CI 3.28-7.41,P<.001)。
  • 次佳组较最佳组超声假阴性率OR 3.90(95%CI 1.02-15.00,P=.04)。

临床应用与阅片要点

  • 超声监测报告应记录US LI-RADS可视化评分,评分B或C者超声假阴性率较高。
  • 对可视化评分B或C的慢性乙肝患者,超声监测可能需结合其他影像方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background US is a standard surveillance tool of hepatocellular carcinoma (HCC), but its effectiveness varies depending on the degree of fibrosis or steatosis and the etiologies of liver disease. Purpose To evaluate the detection power of US and the occurrence of HCC according to the US Liver Imaging Reporting and Data System (LI-RADS) visualization score in chronic hepatitis B (CHB). Materials and Methods Consecutive patients with CHB undergoing regular US surveillance of HCC at a tertiary referral hospital were retrospectively included in this study. During the follow-up, all patients underwent regular HCC surveillance mainly with US and, in some cases, alternative CT or MRI. Outcomes of interest included cumulative incidence of HCC and false-negative rate of US in the optimal (LI-RADS visualization A) versus suboptimal groups (visualization B or C). Cox regression analysis was conducted to calculate the hazard ratio (HR) of HCC occurrence. Results A total of 2002 patients (median age, 54 years [IQR, 46-60 years]; 1192 men) were included: 972 and 1030 in the optimal and suboptimal groups, respectively. Causes of suboptimal visualization included parenchymal heterogeneity from advanced cirrhosis (n = 489), limited penetration from fatty liver (n = 200), and limited window from overlying organ shadow (n = 341). During a median follow-up of 75 months (IQR, 69-77 months), 163 patients developed HCC. Compared with the optimal group, the suboptimal group had a higher risk of HCC (2.38% per year vs 0.48% per year: hazard ratio, 4.93; 95% CI: 3.28, 7.41; P < .001) and higher odds of a false-negative rate of US (43.9% vs 16.7%: odds ratio, 3.90; 95% CI: 1.02, 15.00; P = .04). Conclusion Among patients with CHB, those with suboptimal US LI-RADS visualization of B or C had a higher risk of HCC and higher odds of false-negative rates of US for detecting HCC than those with optimal visualization of A. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Barr and Scoutt in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Park MK, Lee DH, Hur BY, et al. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score. Radiology. 2023. PMID: 37249427. doi:10.1148/radiol.222106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。